On Health Policy Archives

Statement of NCHR President on Introduction of Prescription Drug Affordability Act of 2015

September 10, 2015. We applaud Sen. Sanders and Sen. Cummings’ bill.

NCHR Testimony at FDA on the Reauthorization of the Medical Device User Fee Act (MDUFA)

July 13, 2015. MDUFA should protect the public health by improving the safety and efficacy of all medical products, whether PMA or 510(k).

NCHR Position regarding the House of Representatives Passage of the 21st Century Cures Act

July 10, 2015. NCHR President Diana Zuckerman discusses how the 21st Century Cures Act undermines undermine scientific evidence used to approve medical products.

NCHR Testimony at FDA: Gastroenterology and Urology Devices Panel

May 14, 2015. We enthusiastically support increased transparency with patients during the informed consent process about the risks of infection transmission during the ERCP procedure. Patients are entitled to full disclosure of the potential risks of any procedure or treatment they receive.

Letter to the Dietary Guidelines for Americans Committee (DGAC) Regarding the Dietary Guidelines for Americans (DGA)

May 8, 2015. NCHR gives our opinion on the expert report prepared for the eighth edition of the Dietary Guidelines for Americans (DGA) by the Dietary Guidelines for Americans Committee (DGAC). Overall, we strongly support the conclusions and policy recommendations in the report.